Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aernoud T L Fiolet

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Translational Research|July 11, 2020
Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial InfarctionMax J M Silvis, Evelyne J Demkes, Aernoud T L Fiolet, et al.
Plos One|September 1, 2020
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive proteinAernoud T L Fiolet, Max J M Silvis, Tjerk S J Opstal, et al.
Stroke|September 25, 2024
Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular DiseaseMichiel H F Poorthuis, Steven H J Hageman, Aernoud T L Fiolet, et al.
Journal of the American College of Cardiology|July 26, 2023
C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular DiseasePascal M Burger, Stefan Koudstaal, Arend Mosterd, et al.
Plos One|May 2, 2015
Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical OutcomeJetske van 't Sant, Aernoud T L Fiolet, Iris A H ter Horst, et al.
BMC Cardiovascular Disorders|April 13, 2021
Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learnedMax J M Silvis, Gerardus P J van Hout, Aernoud T L Fiolet, et al.
American Heart Journal|November 10, 2019
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristicsStefan M Nidorf, Aernoud T L Fiolet, John W Eikelboom, et al.
Journal of the American Heart Association|May 15, 2025
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 TrialNiekbachsh Mohammadnia, Britta E Wesselink, Willem A Bax, et al.
Plos One|January 7, 2022
Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19Marissa J M Traets, Roel H T Nijhuis, Servaas A Morré, et al.
Acta Neuropsychiatrica|August 22, 2014
Neurosyphilis in the mixed urban-rural community of the NetherlandsIngrid M Daey Ouwens, Femke D H Koedijk, Aernoud T L Fiolet, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Translational Research|July 11, 2020
Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial InfarctionMax J M Silvis, Evelyne J Demkes, Aernoud T L Fiolet, et al.
Plos One|September 1, 2020
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive proteinAernoud T L Fiolet, Max J M Silvis, Tjerk S J Opstal, et al.
Stroke|September 25, 2024
Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular DiseaseMichiel H F Poorthuis, Steven H J Hageman, Aernoud T L Fiolet, et al.
Journal of the American College of Cardiology|July 26, 2023
C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular DiseasePascal M Burger, Stefan Koudstaal, Arend Mosterd, et al.
Plos One|May 2, 2015
Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical OutcomeJetske van 't Sant, Aernoud T L Fiolet, Iris A H ter Horst, et al.
BMC Cardiovascular Disorders|April 13, 2021
Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learnedMax J M Silvis, Gerardus P J van Hout, Aernoud T L Fiolet, et al.
American Heart Journal|November 10, 2019
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristicsStefan M Nidorf, Aernoud T L Fiolet, John W Eikelboom, et al.
Journal of the American Heart Association|May 15, 2025
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 TrialNiekbachsh Mohammadnia, Britta E Wesselink, Willem A Bax, et al.
Plos One|January 7, 2022
Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19Marissa J M Traets, Roel H T Nijhuis, Servaas A Morré, et al.
Acta Neuropsychiatrica|August 22, 2014
Neurosyphilis in the mixed urban-rural community of the NetherlandsIngrid M Daey Ouwens, Femke D H Koedijk, Aernoud T L Fiolet, et al.
Pageof 4